Tobi Coker

Tobi Coker, Seed Investor at Granza Bio

Tobi Coker is a Deal Partner on the Investment team at Felicis Ventures, which led the $7.14M seed round in Granza Bio, a biotechnology company developing a novel delivery platform for cancer treatments and genetic medicines.123

Key facts about Tobi Coker:

• Previously an investor at The Production Board (TPB), a Bay Area-based early-stage venture firm, where he helped found and seed six companies in life sciences and human health3
• Started his career in Investment Banking and Capital Markets at Morgan Stanley, providing coverage to healthcare and biotechnology companies3
• Currently a Kauffman Fellow, class of 28, and an active member of BLCK VC3
• Received a B.S. degree in Biology, with a minor in Economics from Georgetown University3

Tobi Coker is excited about Granza Bio's "cool, novel approach in fighting cancer" and believes their work will be "fundamental for turning promising discoveries in genetic medicine and cancer therapeutics into impactful treatments for patients".17

Granza Bio's Seed Funding

Granza Bio, founded in 2024 by researchers from the University of Oxford, raised the $7.14M seed round led by Felicis and Refactor, with participation from Y Combinator and notable angel investors.12456 The company is developing a delivery platform to direct therapeutic cargo like "attack particles" - a powerful suite of weapons in the immune system - against diseases such as cancer, autoimmune disorders, and infections.12